OHSU Commercialization Conference, Sept. 14

The signature conference of OHSU Technology Transfer and Business Development connects OHSU innovators, industry partners, investors, and community collaborators. The day includes startup pitches, insights from industry thought leaders, and successful collaboration stories.

In the first panel of the 2017 Commercialization Conference, Brian Druker, M.D., and four industry leaders will discuss breakthroughs that are transforming healthcare. Harry Glorkian from GE Ventures will moderate the panel that includes Druker, Brian Lawrence from global technology company Welch Allyn/Hill-Rom, John Hill from GE, and Sam Adams from IBM.

Register today
Thursday, Sept. 14, 2017
7:30 a.m. – 7 p.m.
Collaborative Life Sciences Building

What’s in store—some highlights:
Industry trends:

  • Executive panel: Breakthrough innovations transforming healthcare
  • Pharma’s transition from internal R&D to external collaborations
  • Role of molecular imaging in the modern era of medicine
  • Women’s contributions to innovation in science and business

Strategies for funding:

  • Drawing interest from VC’s and Angel investors
  • Alternative funding for innovation and startup companies

The 2017 slate of speakers includes two keynote speakers:

  • William Ruh, digital transformer and CEO of GE Digital
  • Gerry Langeler, venture capitalist and managing director of OVP Venture Partners

All OHSU faculty, researchers, students, and staff are welcome to attend. Speaker information and the full agenda can be found at the 2017 Commercialization Conference website.

Bookmark and Share

Comments are closed.

About the Author

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.